Clinical implications of the dry mouth - Oral mucosal diseases

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 156-162

  Jensen, J L ^a   Barkvoll, P ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; DODECYL SULFATE SODIUM; SALIVA SUBSTITUTE; TOOTHPASTE; TRICLOSAN;

BURNING MOUTH SYNDROME; CANDIDIASIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE PREDISPOSITION; HUMAN; HYPOSALIVATION; MOUTH HYGIENE; MOUTH MUCOSA; SALIVARY GLAND DISEASE; SMOKING CESSATION; XEROSTOMIA;

EID: 0031958778     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09643.x     Document Type: Article

References (19)

1. ÖSTERBERG, T., S. LANDAHL. & B. HEDEGARD. 1984. Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. J. Oral Rehabil. 11: 157-170.
2. NEDERFORS, T. 1996. Xerostomia: Prevalence and pharmacotherapy with special reference to ß-adrenoceptor antagonists. Thesis, University of Gothenburg, Sweden.
3. Fox, P.C., K.A. BUSCH & B.J. BAUM. 1987. Subjective reports of xerostomia and objective measures of salivary gland performance. JADA 115: 581-4.
4. MANDEL, I.D. 1989. The role of saliva in maintaining oral homeostasis. JADA 119: 298-304.
5. TQBAK, L.A., M.J. LEVINE, I.W. MANDEL & S.A. ELLISON. 1982. Role of salivary mucins in the protection of the oral cavity. J. Oral Pathol. 11: 1-17.
6. Meeting report. Third European Congress of Oral Medicine. 1997. Oral Dis. 3: 43-48.
7. LAMEY, P-J. 1996. Burning mouth syndrome. Dermatol. Clin. 14: 339-354.
8. HERLOFSON, B.B. & P. BARKVOLL. 1996. The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers. Acta Odontol. Scand. 54: 150-153.
9. BARKVOLL, P. 1992. Considerations concerning the sodium lauryl sulfate content of dentifrices as an ingredient of dentifrices. In Oxford Press, London. G. Embery & G. Rolla, Eds. Clinical and Biological Aspects of Dentifrices.
10. BARKVOLL, P. & G. RÖLLA. 1994. Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J. Clin. Periodontol. 21: 717-719.
11. KJÆRHEIM, V., P. BARKVOLL, S.M. WAALER & G. RÖLLA. 1995. Triclosan inhibits histamineinduced inflammation in human skin J. Clin. Periodontol. 22: 423-426.
12. GAFFAR, A., D. SCHERL, J. AFFLITTO & E.J. COLEMAN. 1995. The effect of triclosan on mediators of gingival inflammation. J. Clin. Periodontol. 22: 480-484.
13. KJAERHEIM, V., A. ROED, P. BRODIN & G. ROLLA. 1995. Effects of triclosan on the rat phrenic nerve-diaphragm preparation. J. Clin. Periodontol. 22: 488-493.
14. BLACK, J.G., D. HOWES & T. RUTHERFORD. 1975. Percutaneous absorption and metabolism of Irgasan® DP300. Toxicology 3: 33-47.
15. SKAARE, A.B., G. EIDE, B.B. HERLOFSON & P. BARKVOLL. 1996. The effect of toothpaste containing triclosan on oral mucosal desquamation-A model study. J. Clin. Periodontol. 23: 1100-1103.
16. SKAARE, A.B., B.B. HERLOFSON & P. BARKVOLL. 1996. Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers. J. Clin. Periodontol. 23: 778-781.
17. ATKINSON, J.C., C. DAWES, T. ERICSON, P.C. Fox, B.K. GANDARA, D. MALAMUD, I.D. MANDEL, M. NAVAZESH & L.A. TABAK. 1993. Guidelines for saliva nomenclature and collection. In Saliva as a Diagnostic Fluid. D. Malamud & L. Tabak, Eds.: 694: xi-xii. Annals of the New York Academy of Sciences. New York.
18. JENSEN, J.L., T. UIILIG, T.K. KVIEN & T. AXELL. 1997. Characteristics of rheumatoid arthritis patients with self-reported sicca symptoms: Evaluation of medical, salivary and oral parameters. Oral Dis. 3: 254-261.
19. Fox, P.C., J.C. ATKINSON, A.A. MACYNSKI, A. WOLF, D.S. KUNG, I.H. VALDEZ, W. JACKSON, R.A. DELAPHENA, J. SHIROKY & B.J. BAUM. 1991. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch. Intern. Med. 151: 1149-1152.